FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 19613467 · Received June 26, 2024

Report

Report Number
1823260-2024-01858
Event Type
Malfunction
Date Received
June 26, 2024
Date of Event
June 1, 2024
Report Date
September 6, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FIELD SERVICE REPRESENTATIVE REPLACED THE PROBE AND PERFORMED ADJUSTMENTS. HE PERFORMED CHECKS WITH ACCEPTABLE RESULTS. AFTER SERVICE, NO ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Additional Manufacturer Narrative · 0

THE REAGENT LOT NUMBERS AND EXPIRATION DATES WERE NOT PROVIDED. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE GLUCOSE RESULTS FOR 2 PATIENT SAMPLES AND QUESTIONABLE CALCIUM AND ALBUMIN RESULTS FOR 1 PATIENT SAMPLE ON A COBAS C 503 ANALYTICAL UNIT. PATIENT 1 (ID:(B)(6): THE INITIAL GLUCOSE RESULT WAS 5 MG/DL AND THE REPEATED RESULT WAS 183 MG/DL. PATIENT 2 (ID: (B)(6); THE INITIAL CALCIUM RESULT WAS 5.5 MG/DL AND THE REPEATED RESULT WAS 9.4 MG/DL. THE INITIAL ALBUMIN RESULT WAS 1.5 G/DL AND THE REPEATED RESULT WAS 3.3 G/DL. PATIENT 3 (ID: (B)(6): THE INITIAL GLUCOSE RESULT WAS 62 MG/DL. THIS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE REPEATED RESULT WAS 143 MG/DL. THE REPEATED RESULTS WERE TESTED ON ANOTHER MODULE AND WERE DEEMED CORRECT. THE SAMPLES WERE REPEATED BECAUSE THE INITIAL RESULTS APPEARED LOW FOR THE PATIENTS' PROFILE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
702074 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown